Thermo Fisher Scientific Inc.(TMO)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
TMO | 254.15 B | 37.00x | 10.50% | 15.04% | $18.58 | 13.52% | 0.81x | 0.26% | $704.00 | $435.27 |
NTRA | 58.51 B | - | 37.70% | -7.11% | -$1.35 | -12.54% | 0.13x | 0.00% | $437.41 | $181.00 |
ILMN | 40.46 B | 49.99x | 9.40% | 18.34% | $5.36 | 32.34% | 0.89x | 0.00% | $309.35 | $94.00 |
GH | 21.82 B | - | 44.30% | -38.33% | -$3.50 | - | - | 0.00% | $191.05 | $66.59 |
VCYT | 3.60 B | 31.99x | 15.50% | 20.37% | $1.40 | 8.77% | 0.03x | 0.00% | $60.91 | $29.45 |
Peer Valuation & Performance Analysis
Peer group analysis for Thermo Fisher Scientific Inc. (TMO) compared to its primary competitors (including NTRA, ILMN, GH) reveals distinct metrics. TMO trades at a valuation premium compared to its competitors, with a P/E ratio of 37.0x versus the peer average of -66.3x (representing a -156% premium). This indicates that the market expects superior growth or commands a quality premium for TMO. In terms of growth, TMO's revenue growth of 10.5% lags behind the peer average of 26.7%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 15.0% compared to the peer average of -1.7%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• TMO ranks #2 in P/E ratio, #4 in revenue growth, and #3 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $680.17 | $693.37 | $679.32 | $687.37 | 3,525,846 | +1.18% |
| 2026-10-19 | $691.31 | $692.99 | $673.47 | $679.38 | 2,403,800 | -1.54% |
| 2026-10-16 | $692.26 | $699.20 | $683.63 | $690.00 | 2,106,500 | -0.93% |
| 2026-10-15 | $686.13 | $704.00 | $671.47 | $696.49 | 3,962,800 | +3.46% |
| 2026-10-14 | $664.01 | $681.50 | $659.00 | $673.20 | 2,485,700 | +1.53% |
| 2026-10-13 | $662.84 | $666.38 | $655.73 | $663.04 | 2,299,300 | +0.12% |
| 2026-10-12 | $657.23 | $662.54 | $652.50 | $662.24 | 1,384,600 | +0.64% |
| 2026-10-09 | $650.00 | $661.94 | $644.16 | $658.02 | 1,580,700 | +0.93% |
| 2026-10-08 | $657.53 | $658.56 | $635.32 | $651.98 | 2,585,500 | -1.52% |
| 2026-10-07 | $662.40 | $671.67 | $651.12 | $662.06 | 1,825,300 | +0.83% |
| 2026-10-06 | $683.35 | $694.33 | $654.51 | $656.58 | 2,748,200 | -2.98% |
| 2026-10-05 | $648.04 | $676.76 | $648.04 | $676.76 | 2,124,400 | +3.35% |
| 2026-10-02 | $654.15 | $659.47 | $648.29 | $654.80 | 1,667,700 | +0.35% |
| 2026-10-01 | $672.39 | $673.12 | $651.77 | $652.51 | 2,375,300 | -3.34% |
| 2026-09-30 | $675.95 | $683.63 | $671.63 | $675.05 | 2,323,500 | -0.67% |
Explore More Analysis for TMO
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.